[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH OCRELIZUMAB IN ADULT PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

Upstate Institutional Review Board (IRB) Number:

1724220

Patient Age Group:

Adults

Principal Investigator:

Corey A McGraw

Who can I contact for more information?

Name: Sigiriya E Smolen
Phone: 315-464-9767
Email: smolens@upstate.edu

Return to Previous Page || Search Again

Top